Navigation Links
Mindray Announces 2008 Fourth Quarter and Full Year Results
Date:3/4/2009

Net Income

Fourth quarter 2008 non-GAAP net income increased 43.0% year-over-year to $36.0 million from $25.2 million in the fourth quarter 2007. Fourth quarter 2008 GAAP net income was $31.6 million compared to $21.5 million in the fourth quarter 2007. Non-GAAP net margin was 21.4% in the fourth quarter 2008 compared to 27.6% in the fourth quarter 2007 and 23.0% in the third quarter 2008. GAAP net margin was 18.8% in the fourth quarter 2008 compared to 23.6% in the fourth quarter 2007 and 19.1% in the third quarter 2008. Fourth quarter 2008 income tax expense was $0.3 million representing an effective tax rate of 1.0% compared to a 16.9% effective tax rate in the fourth quarter 2007.

Fourth quarter 2008 basic and diluted non-GAAP earnings per share were $0.33 and $0.32, respectively. Fourth quarter 2008 GAAP basic and diluted earnings per share for the quarter were $0.29 and $0.28, respectively. Shares used in the computation of diluted earnings per share decreased from 113.5 million in the fourth quarter 2007 to 112.3 million in the fourth quarter 2008.

In the fourth quarter 2008, the Shenzhen subsidiary received approval of its application for hi-tech enterprise qualification from the relevant government authorities. Prior to the approval, the company accrued income tax for its Shenzhen subsidiary where the income tax rate is 18% in 2008. Following the approval, the total income tax reversed for the full year 2008 was $4.1 million in the fourth quarter 2008, which resulted in the lower tax rate for the fourth quarter and full year 2008 for the company.


    SUMMARY - 12 Months Ended December 31, 2008

    (US$ millions, except per-share data)    YE/2008     YE/2007     % change
    Revenue generated in China                 234.5       145.5        61.1%
    Revenue generated in international
     markets                                   313.1       148.8       110.4
'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Mindray Medical International Announces Second Quarter 2008 Results
2. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
3. Mindray Medical International Announces First Quarter 2008 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces Third Quarter 2007 Results
6. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Martek Announces First Quarter 2009 Financial Results
9. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
10. STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Ceres, Inc. (Nasdaq: ... a U.S. patent for a genetic sequence derived from ... as research, product development and plant transformation. The company ... biosynthetic processes that are the target of a class ... companies a commercial license to the innovation, including an ...
(Date:5/26/2015)... and BELLINGHAM, Washington, USA (PRWEB) May 26, 2015 ... signed a formal partnership with the Max Planck ... for Extreme and Quantum Photonics. The center will link ... field of photonics, and will be only the third ... of SPIE, the international society for optics and ...
(Date:5/26/2015)... California and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... of its QIAGEN Clinical Insight ® (QCI™) ... labs to interpret and report on genomic variants ... supported applications for the bioinformatics platform are in ...
(Date:5/26/2015)... FL (PRWEB) May 26, 2015 ... Inc. have announced plans for the company’s first cellular ... 2015, followed by a full day, hands-on stem cell ... by J. Victor Garcia Gimenez, M.D., President of Therapeutic ... the medical community’s increasing interest in regenerative medicine and ...
Breaking Biology Technology:Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3
... Antonio Breast Cancer Symposium, AMSTERDAM, Netherlands, Dec. ... evolving field of molecular diagnostics, announced,today that an ... its MammaPrint(R) breast cancer prognosis test in,patients who ... that,MammaPrint(R) can accurately identify a low risk group ...
... Patients treated with drug-eluting,stents must take a ... at least one year, and possibly longer, after ... guideline update published,online today in the journals of ... College of Cardiology (ACC), and,American Heart Association (AHA). ...
... Dec. 13 Sangart, Inc., a privately held,biopharmaceutical ... oxygen transport agents, today announced that an,independent data ... both Phase III clinical trials of Sangart,s lead ... recommendation follows the DSMB,s review of the blinded ...
Cached Biology Technology:MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients 2MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients 3PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 2PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 3PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 4Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) 2
(Date:5/26/2015)... May 26, 2015 Research ... addition of the "Saudi Arabia Biometric Systems ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric ... is projected to grow at over 22% ... is attributed to the surging demand for better ...
(Date:5/21/2015)... May 21, 2015 According ... Market by Solutions (Hardware, Software, Services), by Applications (Surveillance ... others), by End-Users (Military & Defense & Commercial) ... Thermal Imaging Market is expected to grow from ... 2020, at a Compound Annual Growth Rate (CAGR) ...
(Date:5/19/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... gum disease, is an independent risk factor for head ... for increased efforts to prevent and treat periodontitis as ... form of cancer. "Prevent periodontitis; if you have ... said Mine Tezal, D.D.S., Ph.D., assistant professor in the ...
... are developing diversionary tactics to fool disease-causing bacteria in ... gut infections, such as cholera, produce toxins that damage ... displayed on the surface of cells in the host,s ... meeting at Heriot-Watt University, Edinburgh, today (8 September), Professor ...
... reveal not only the "lifestyle" of marine microbes but of ... researchers may be able to predict the types of microbes ... of just a few dominant species, according to research co-author ... well, it may reveal new insights into the impacts of ...
Cached Biology News:Prevent periodontitis to reduce the risk of head and neck cancer 2Designing probiotics that ambush gut pathogens 2Genomes reveal bacterial lifestyles: Research 2
... designed for RNA aptamer screening and binding ... powerful Paraflo microfluidic on-chip synthesis platform. Thousands ... synthesized on-chip and LC Sciences can provide ... are available as part of our comprehensive ...
... is commonly used as a fusion partner ... The GSTTag sequence has been reported to ... the solubility of its fusion partners. When ... GSTTag fusion proteins can be purified with ...
... next step in the evolution of laboratory ... that delivers labware to multiple laboratory instruments, ... the throughput of ordinary microplate robots. It ... of configurations to meet any labs specific ...
... use of small interfering RNA (siRNA) molecules ... interference (RNAi) pathway have generated tremendous interest ... siRNA for experimental use can be synthesized ... then transfected into the target cells in ...
Biology Products: